Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can't trade it with Fidelity..."Stop Sign".
It certainly is running, MT...and maybe a "sell the news", and take a nice profit, by the EOW, after we get Trump's signature.
$HEMP >>>>> GOING GANGBUSTERS!!!!!
$UBQU$... Ubiquitech Software...AKA "HempLife Today" TM and "CannazALL" TM product line.
Anouncing a legal retainer to change the name, and ticker symbol, to "HempLife Today"...ASAP!
Also, discontinuing ALL EFFORTS AND $$$$ RESOURCES currently put into it's "CriptoBuy" Division and, redirecting them to "HempLife Today" in it's entirety!!
IMO... A HUGE DEVELOPMENT, AT THE PERFECT TIME, with the "Hemp Farming Act of 2018, about to be signed into law, with the Farm Bill 2018!
Eye-opening as well, as of 10/17... "HempLife Today Among the Top Five Hemp CBD Companies in Gross Annual Product Sales!"
The current SP, stands at .0013!!! <-- Check it out!
Ubiquitech Software Corp. Engages Law Firm to Officially File for Name Change to HempLife Today
BY GlobeNewswire
— 7:00 AM ET 12/14/2018
Denver, CO, Dec. 14, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Ubiquitech Software Corp. ( UBQU ) is formally announcing to shareholders that it has retained a law firm to officially file a name change to HempLife Today™.
The Company believes that due to the new positive federal legislation under the new 2018 Farm Bill, expected to be signed into law this month, and the growing HempLife Today™ brand of CannazALL™ CBD products, the time has come to officially change the Company name to HempLife Today™, and the new symbol will be announced once approved.
The Company has retained the services of a legal team that specializes in name changes for OTC stock companies, and is now working with this team to expedite the said name change as quickly as possible.
CEO James Ballas stated, “We have always wanted to change our name to HempLife Today for many very obvious reasons. However, because of the need to protect the Company in a legally challenging product field, the desire to protect the Company and shareholders in case legislation did not fall positively in the industry, and the necessity to have other income streams for the Company if needed, the name change decision was put on hold until now. So, we are now extremely excited to make this announcement that we are committed to becoming one hundred percent HempLife Today, now, and in the future, and our complete Company focus will be on making HempLife Today the finest in the industry.”
The Company will not be pursuing its CryptoBuy division at this time and all Company resources will be used by HempLife Today™. In addition, Blue Crush Marketing Group, the in-house marketing Company that creates advertising campaigns for HempLife Today™, will remain in place but will not be part of the new publicly traded symbol, as the Company wants shareholders to know the complete commitment it has to the new HempLife Today™ brand.
COO Luke Dreyer stated, “I really consider our name change to be the biggest announcement the Company has made to date, and this should get shareholders excited as well. Because, we will now be operating in a totally legal space with no confusion or blurred lines, and our Company name will now reflect what we do. We are HempLife Today.”
The Company will keep shareholders informed on the progress of the name change to HempLife Today™, and also the new trading symbol that is granted. The Company will also keep shareholders informed on all Company progress as it moves into 2019 with a full commitment to what will be a potential 20 billion dollar industry by 2022.
Ubiquitech Software Corp. Engages Law Firm to Officially File for Name Change to HempLife Today...Nasdaq
HempLife Today Among the Top Five Hemp CBD Companies in Gross Annual Product Sales...Forbes Magazine
Hemp Cannabis Product Sales Projected To Hit $1 Billion In 3 Years...Forbes 10/23/17
UBQU Stock Quote...Yahoo
CRLBF Cresco Labs. New boy on the block. Impressive earnings. Also, CBD huge potential, CWEB CVSI, but that does not mean squat in this dire environment.
Okay, thanks. I just compared the 2 ETFs on the same chart...% return over time. They track each other damn near perfectly, but your MJ fund generally yields better returns...
September 4th to present (the day we bought our first pot stock):
MJ: -22.1%
HMMJ: -31.6%
YTD:
MJ: -28.0%
HMMJ: -36.5%
You can see that while MJ does better than HMMJ its performance ain't exactly anything to write home about either.
These miserable returns may show what I have suspected...that it might be a lot better to swing trade these MJ stocks rather than hang onto them long-term and always have constant exposure no matter what.
Think I'll just keep on doing what I've been doing all along, and if I start performing as poorly as these guys I'll just quit trading altogether and find a new hobby. Maybe I'll take up throwing darts...it appears to be what these fund managers have been playing.
I did trade MJ when it was new. I like MJ in the 27's. There are a few opportunities that stick out. Namaste, Liberty Health, Curealeaf. Possibly Trulieve. If you see Crop at 22 cents. I like CVSI in the 4's. Thursday was brutal. We can certainly use a break from the red.
Why ain't Sproutley on that list??? LOL
Hey, John...my old man wants to give me even more of his money to play around with...guess he ain't too happy with how his Schwab & Gabelli funds have been performing. So I'm trying to gauge how I've been doing before I agree to take on the extra responsibility.
I took a look at the Horizons MJ ETF (biggest pot ETF in the world) so I could compare myself to something. Our first pot trade started on September 4th...if we had just put everything into this "professionally managed" ETF we'd be down a whopping 32% right now!
https://www.marketwatch.com/investing/fund/hmlsf
Now I am certainly no financial whiz or the sharpest swing trader in the world by any means, but we are still up double digits since I started even after a rough few weeks lately. I am not very impressed by how this ETF is performing at all. You ever trade these things or do you just stick to individual stocks yourself like I've been doing so far?
This ETF better get some new fund managers if a clueless newbie like me can beat them.
China Hemp $CIIX .58 +0.002 (+0.35%) Solid play
My holdings
Namaste
Liberty Health
Cronos
Curaleaf
CV Sciences
Trulieve
Charlotte's Web
Terrascend
Origin House
Yeah, maybe not. Trying to get a handle on weather I should be myself. What is your take
Not keen on Leaf.
FrLf a possible add then. Hammered down too
Cvsi, web, ect ect
Hitch your wagon to the CBD train.
Dollar off sale!!
Tried a vape first time in Washington. Perfect way to go. Did not like sativa ( paranoid ) but the indica felt very natural and calming.
A couple of interesting Micro-cap CBD Beverage plays, to consider DD...ing.
Especially, before the Farm Bill is finalized.
HIPH, KGKG..both with some considerable up-side potential...IMO!
PS PURA, makes it an even three!
All above..imo
Havn't fired up a "bone" in 40 years, John, but I do love me some MJ Cannabis Sector tickers...especially, now, and those of the U.S. Hemp / CBD industry variety!!
These Are The Top 3 Marijuana Stocks in CBD Oil Right Now
By Laura Kuhl - Pot Network
JUL 03, 2018
Aphria Inc.
Aphria Inc. (TSX:APH) is a marijuana stock that is worth the investment right now. And their role in CBD oil extraction and distribution is part of the reason why. They recently set their sights on the South American market by becoming the exclusive supplier for ColCanna SAS.
ColCanna SAS is the first cannabis cultivator to receive a license to grow cannabis in Colombia’s luxuriant coffee zone. The company’s licenses for THC and CBD extraction are also pending. In the meantime, Ahpria is providing the company with cannabis products to further research and development. The end goal is to establish ColCanna as a supplier of Aphria’s pharmacy-grade CBD oil in South America, a move that could set Aphria up quite nicely and give them a chance to dominate the CBD market.
Scythian Biosciences Corporation (TSXV.SCYB) is in the process of acquiring ColCanna SAS, and the three companies are working together with an international supply agreement.
Isodiol International Inc.
May was a “historic month” for this marijuana stock. Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) CEO Marcos Argamont said as much in the company’s corporate update on June 11, which included the CAD$3.3 million the company earned last month in unaudited revenue.
And Isodiol has put in the work over the past couple of months. In May, they signed a licensing agreement with Liberty Health Sciences (CSE.LHS) (OTC.LHSIF) to bring a suite of CBD treatments to Florida and Massachusetts. And earlier in April, the company was approved to use their strains of CBD as an Active Pharmaceutical Ingredient. Isodiol’s strains are the first to be developed as 99 percent pure, and the company intends to develop a range of high-quality CBD products with their purified strains.
While CBD oil faces legal challenges at the federal level, Isodiol’s strategic moves into the American CBD market make them a marijuana stock to watch.
GW Pharmaceuticals
GW Pharmaceuticals (NASDAQ:GWPH) is setting the bar quite high for marijuana stocks when it comes to CBD oil. They made headlines as the first pharmaceutical company to have a cannabis-based drug approved by the FDA, and it is only starting to pave the way for more.
GW Pharmaceuticals is confident their new drug Epidiolex will receive the same warm reception as their first. Sativex is used to treat muscle spasticity, a symptom of Multiple Sclerosis (MS), and is already in Phase 3 of testing. It contains a one-to-one ratio of CBD to THC. Marketing permissions are already approved in 21 countries across the European Union.
Earning FDA approval for Epidiolex was a major feat, but it is entirely too early in the game to know what happens next. If anything, GW Pharmaceuticals could start changing the way people look at CBD oil, and that would be good news for marijuana stock investors.
How to Invest in the Fast Growing Cannabidiol ... - Profit Confidential
https://www.profitconfidential.com › Marijuana
Sep 5, 2018 - We take a look at 10 of the best CBD oil stocks available now. ... Home » Marijuana » How to Invest in the Fast Growing Cannabidiol Industry.
Company Name Stock Ticker
Neptune Technologies & Bioressources Inc NASDAQ:NEPT
Aurora Cannabis Inc OTCMKTS:ACBFF, TSE:ACB
Isodiol International Inc OTCMKTS:ISOLF, CNSX:ISOL
Aphria Inc OTCMKTS:APHQF, TSE:APH
Canopy Growth Corp NYSE:CGC
CV Sciences Inc OTCMKTS:CVSI
CannaRoyalty Corp OTCMKTS:CNNRF, CNSX:CRZ
MPX Bioceutical Corp OTCMKTS:MPXEF, CSNX:MPX
Golden Leaf Holdings Ltd OTCMKTS:GLDFF, CSNX:GLH
GW Pharmaceuticals PLC NASDAQ:GWPH
3 Cbd Oil Stocks That Will Make You Rethink Your Portfolio | PotNetwork
https://www.potnetwork.com/.../3-cbd-oil-stocks-will-make-you-rethink-your-portfoli...
Apr 27, 2018 - Even as cannabis stocks continue to experience volatility, CBD oil sees record profits. ... playing field with any of the top marijuana stocks in the industry. .... marijuana stock is in many ways the standard in the CBD oil game.
Isodiol International Inc.
Global Bioactive CBD oil company Isodiol International Inc. (CSE:ISOL) (ISOLF) announced recently the acquisition of several global assets, placing them on a level playing field with any of the top marijuana stocks in the industry. Along with their recent deals, the company has begun to develop a new facility in China where they plan to take certified organic hemp and extract cannabinoids and terpenes.
Isodiol’s new strategic assets in the U.K., Brazil, and China look like they will give the company true global dominance in the growing CBD oil sector; a pot stock so steeped in extracts that CBD oil stock seems the more appropriate term. “These transactions mark major milestones for Isodiol. The acquisitions ensure the company has a continued source of CBD and scalability of production as our international expansion continues to generate additional market demand for our products,” remarked CEO Marcos Agramont.
Isodiol currently trades at $0.84 on the OTC markets, with a market cap of $240 million. With the growth in the CBD oil market set on an upwards trajectory, now may be the time for investors to consider this globally dominant cannabis stock —cbd oil stock option.
Neptune Wellness Solutions
Wellness products company Neptune Wellness Solutions (NASDAQ:NEPT) (TSX:NEPT) announced earlier this year a partnership with Tetra Bio-Pharma Inc. to develop, commercialize, and market cannabinoid oil products for pain and inflammation. The former krill oil supply company made a move towards the CBD market last year and has not looked back, making the newest player in the CBD oil stock market the most intriguing.
In a presentation explaining the move to the CBD oil business, Neptune called it a natural fit, with the company sliding from one wellness product to another. As CEO Jim Hamilton said in an interview with The Cannabist, “[Customers are] looking for inflammation [treatments], they’re looking for sleep aids, they’re looking for anxiety relief. Think of all the people taking sleeping pills and all the people taking opioids. I think there’s a whole community that is going to want to embrace elements of this business.”
Neptune currently trades at $2.90 on the Nasdaq with a market cap of $225 million. A new entrant into the marijuana stock market, their foray into CBD oil makes them an intriguing look for investors.
Medical Marijuana Inc.
The aptly named Medical Marijuana Inc. (OTC:MJNA) announced recently that March 2018 was the company’s best month ever for revenues. With their popular subsidiary Kannaway under their belt and a popular online CBD oil store, the first-ever publicly-traded marijuana stock is in many ways the standard in the CBD oil game.
"March, 2018 was the largest revenue month in the history of our Company. We look forward to sharing our full 2017 results in our Annual Report which will be filed this month," said Medical Marijuana, Inc. CEO Dr. Stuart Titus in a statement. Kannaway once again looks to make waves with their Empower National Convention in Las Vegas this April.
Medical Marijuana Inc. currently trades at $0.12 per share with a market cap near $360 million. This is one CBD oil stock on solid ground for any marijuana stock investor.
These Are The Top 3 Marijuana Stocks in CBD Oil Right Now ...
https://www.potnetwork.com/news/these-are-top-3-marijuana-stocks-cbd-oil-right-now
Jul 3, 2018 - As the market begins to see the potential of CBD oil, it is high time ... Aphria Inc. (TSX:APH) is a marijuana stock that is worth the investment right now. ... changing the way people look at CBD oil, and that would be good news ...
Right on, that is low !
Buy Namaste at $1.95 if you want a bargain.
Trading ACBFF and FRLF. Trying to get things that have not taken off yet
Anything cannabis. Vaping, paraphernalia, CBD oil, etc.
Shatterizer!!!!!!!!!!!!!!
https://www.youtube.com/embed/XoH0iBcrixk
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |